Table 3.
Genotype | MIV | IIV | Common | % of common in MIV | % of common in IIV | |
GP Model — Experiment 1 | ||||||
WT | + | 725 | 567 | 501 | 69.10% | 88.36% |
WT | - | 774 | 552 | 515 | 66.54% | 93.30% |
antiPLD | + | 518 | 422 | 357 | 68.92% | 84.60% |
antiPLD | - | 505 | 336 | 313 | 61.98% | 93.15% |
GOT Model — Experiment 2 | ||||||
Col-0 | + | 311 | 227 | 198 | 63.67% | 87.22% |
Col-0 | - | 190 | 122 | 110 | 57.89% | 90.16% |
Cvi-0 | + | 185 | 106 | 89 | 48.11% | 83.96% |
Cvi-0 | - | 97 | 63 | 59 | 60.82% | 93.65% |
ws | + | 326 | 234 | 181 | 55.52% | 77.35% |
ws | - | 482 | 331 | 273 | 56.64% | 82.48% |
Th | + | 363 | 238 | 219 | 60.33% | 92.02% |
Th | - | 251 | 196 | 166 | 66.14% | 84.69% |
ALL | + | 448 | 298 | 249 | 55.58% | 83.56% |
ALL | - | 294 | 202 | 159 | 54.08% | 78.71% |